Status:
TERMINATED
Heart Rate Variability and Emotion Regulation
Lead Sponsor:
University of Southern California
Conditions:
Heart Rate Variability
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Previous research suggests that heart rate variability (HRV) biofeedback aimed at increasing HRV can reduce anxiety and stress. However, some mental quiescence practices that reduce HRV during the pra...
Eligibility Criteria
Inclusion
- Fluent in English
- Aged between 18-35 for the younger group and aged between 55-80 for the older group
- Scores on TELE indicate no current dementia
- Normal or corrected-to-normal vision and hearing
- People taking antidepressant, anti-anxiety medication and/or attending psychotherapy only if the treatment had been ongoing and unchanged for at least three months
Exclusion
- Have a disorder that would impede performing the HRV biofeedback procedures (i.e., abnormal cardiac rhythm, heart disease including coronary artery disease, angina, and arrhythmia, cardiac pacemaker, stroke, panic attack, cognitive impairment).
- Current practice of any relaxation, biofeedback, or breathing technique.
- Currently taking any psychoactive drugs other than antidepressants or anti-anxiety medications
- No trips that would lead them to miss any of the weekly meetings
- Currently nursing, pregnant, or intend to become pregnant
- Have metals in their body, as this is a scanning requirement
- Have any conditions listed in the MRI Screening form (see below)
- MRI screening
- Cardiac pacemaker
- Implanted cardiac defibrillator
- Aneurysm clip or brain clip
- Carotid artery vascular clamp
- Neurostimulator
- Insulin or infusion pump
- Spinal fusion stimulator
- Cochlear, otologic, ear tubes or ear implant
- Prosthesis (eye/orbital, penile, etc.)
- Implant held in place by a magnet
- Heart valve prosthesis
- Artificial limb or joint
- Other implants in body or head
- Electrodes (on body, head or brain)
- Intravascular stents, filters, or
- Shunt (spinal or intraventricular)
- Vascular access port or catheters
- IUD or diaphragm
- Transdermal delivery system or other types of foil
- patches (e.g. Nitro, Nicotine, Birth control, etc.)
- Shrapnel, buckshot, or bullets
- Tattooed eyeliner or eyebrows
- Body piercing(s)
- Metal fragments (eye, head, ear, skin)
- Internal pacing wires
- Aortic clips
- Metal or wire mesh implants
- Wire sutures or surgical staples
- Harrington rods (spine)
- Bone/joint pin, screw, nail, wire, plate
- Wig, toupee, or hair implants
- Asthma or breathing disorders
- Seizures or motion disorders
- Hospitalization for mental or neurological illness
- Head Trauma
- Migraine Headache
- Panic attack
- Stroke
Key Trial Info
Start Date :
February 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2020
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT03458910
Start Date
February 14 2018
End Date
May 5 2020
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90089